MMP26 and prostate carcinoma: Of the MMPs studied, the greatest increase (∼30 fold) in expression levels in malignant compared to nonmalignant prostate tissues was found for MMP26. The expression of MMP26 was also found to correlate strongly with Gleason score, indicating its potential as a prognostic marker in prostate carcinoma.